JPRN-jRCTs041220017
Recruiting
Phase 2
Evaluation of the efficacy and safety of ICG Fluorescence navigation surgery in gastrointestinal cancer
Inaki Noriyuki0 sites310 target enrollmentMay 18, 2022
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Inaki Noriyuki
- Enrollment
- 310
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Patients who were diagnosed with gastric cancer or esophageal cancer(StageI\-III)
- •2 Over 20 years old
- •3 Patients determined to be ready for general anesthesia and surgery
- •4 Performance Status (ECOG) 0 or 1
- •5 Objective procedure: Thoracoscopic esophagectomy, laparoscopic gastrectomy (including robot\-assisted surgery)
- •6 Historical control: Patients who received surgery in Kanazawa University Hospital from January 2018 to
- •October 2021(StageI\-III)
- •7 Patients for whom informed consents were taken
Exclusion Criteria
- •1 History of hypersensitivity to ICG
- •2 Hypersensitivity to iodine
- •3History of asthma or drug allergy
- •4 Judged to be difficult to participate in the study because of mental disorder
- •5 Inappropriate case determined by the principal invstigator/researcher
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical validation of indcyanine-green(ICG) fluorescence making in endoscopic esophagus/gastric cancer surgery.esophageal cancer and gastric cancerJPRN-UMIN000033085Sapporo Medical University50
Recruiting
Not Applicable
Examination of efficacy and safety of PEG-IFN alpha-2a for the treatment of chronic hepatitis B.chronic hepatitis BJPRN-UMIN000006649Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine100
Recruiting
Not Applicable
Examination of efficacy and safety of PEG-IFN alpha-2a plus Adefovir dipivoxil for the treatment of chronic hepatitis Bchronic hepatitis BJPRN-UMIN000006659Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine50
Recruiting
Phase 3
Evaluation of clinical applications of fluorescent imaging to liver surgery using injection of indocyanine green on the previous day of the operatioiver cancersJPRN-UMIN000013112Department of Surgery, Kanai Medical University100
Active, not recruiting
Not Applicable
Clinical study to assess the efficacy and safety of GFT505 80 mg and GFT505 120 mg daily for 52 weeks in Patients with Non-Alcoholic Steatohepatitis (accumulation of fat in the liver associated with inflammation and liver cell injury at microscopic examination of liver biopsy).EUCTR2012-000295-42-ITGENFIT SA270